Dar Al-Shifa Pharmaceuticals Company reported unaudited preliminary earnings results for the full year ended December 31, 2014. For the year, net profit after tax reached $1,746,987, compared with a net profit after tax of $2,117,685 in the audited data for 2013, a net decrease of 17.5%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 USD | +4.69% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 30.15M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PHARMACARE Stock
- News Dar Al-Shifa Pharmaceuticals Company
- Dar Al-Shifa Pharmaceuticals Company Reports Unaudited Preliminary Earnings Results for the Full Year Ended December 31, 2014